HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

COVID-19 Self-Tests Could Hit German Retail Shelves In A Matter Of Weeks

Executive Summary

In Germany, a draft reguation circulated to industry associations proposes the sale of COVID-19 antigen tests directly to the public. If the amendment to Germany's medical devices regulations is approved, the onus will be on manufacturers to submit viable tests for approval, with the country's in-vitro testing industry association suggesting that this could be achieved in a matter of weeks. 

You may also be interested in...



Will Roche Be Among The First To Launch An Approved COVID Self-Test In Germany?

Roche's new CE-marked nasal-swab antigen test could be a good candidate for approval within Germany's recently liberalized COVID-19 self-test market. 

Abbott Mass Distributes Rapid COVID-19 Tests, Offers App So Consumers Can Display Test Results

BinaxNOW rapid tests, the size of a credit card with no other equipment required, are sold directly to organizations at $5 each and an at-home version, with use guided through digital links, is available at $25 per test. It can be paired with NAVICA app, allowing consumers to display negative results through a temporary digital health certificate.

Greens Petition German Parliament For OTC COVID-19 Antibody Self Tests

Commercial COVID-19 antibody self-tests are back on the agenda in Europe, this time in Germany, where the Greens are calling for amendments to the country's medical devices regulations to allow tests to be sold OTC in pharmacies and incentives for industry to quickly scale up production. 

Related Content

Topics

UsernamePublicRestriction

Register

RS150938

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel